June 2026 FDA Recall Medline by Biomed Laboratories, Llc.
D-0663-2026 - Failed Impurities/Degradation Specifications; Formaldehyde levels exceeded specification.

This Class II drug recall was voluntarily initiated by Biomed Laboratories, Llc. on June 11, 2026 for the product Medline. The FDA reported the reason for recall as failed impurities/degradation specifications; formaldehyde levels exceeded specification.. The product was distributed Nationwide and the recall is currently ongoing.

Recall Number: D-0663-2026

Reason for Recall
Failed Impurities/Degradation Specifications; Formaldehyde levels exceeded specification.
Initiated
06-11-2026
Reported
07-15-2026
Quantity
509,652 tubes

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
BioMed Laboratories, LLC.
Nationwide in the US
Medline Remedy Specialized Silicone Cream (Hydraguard-D ),Manufactured for Medline Industries, LP, Three Lakes Drive, Northfield, IL 80090 2 FL OZ (59 mL) NDC 53329-159-13 4 FL OZ (118 mL) NDC 53329-159-04

Batch or Lot Expiration Information

Lot# Lots 0001882643, 0001887165, 0001888441, 0001900835, 0001931329 & 0001951664 May 2026 Lots 0001882644, 0001899186, 0001903516, 0001905970, 0001911902, 0001917707 & 0001920638 June 2026 Lot 0001927080 Oct 2026 Lots 0001937896, 0001952194 & 0001962232, Jan-2027 Lots 0001981964, 0001981965, 0001994680 & 002012768, May 2027 Lot 0001998027, Jun 2027 Lot 002012787, Aug 2027